Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.00
Bid: 1,670.50
Ask: 1,671.00
Change: 17.00 (1.03%)
Spread: 0.50 (0.03%)
Open: 1,650.00
High: 1,677.00
Low: 1,646.00
Prev. Close: 1,653.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK Consumer Confidence Hits Nine-Year High

Fri, 30th May 2014 10:28

LONDON (Alliance News) - The following is a summary of top news stories Friday.
----------
COMPANIES
----------
Polymer products manufacturer Fenner PLC said underlying pretax profit for the year will be 10% to 15% below the prevailing market consensus forecast of GBP77.6 million, as trading conditions in the US continue to deteriorate while its Australian arm suffered a setback following the loss of a profitable contract. In the year ended August 31, 2013, Fenner's pretax profit was GBP67.9 million, down from GBP86.6 million a year earlier. The company, which reported a fall in profit and revenue for the first half earlier this year, said trading conditions in the US have shown no sign of imminent improvement, while the coal industry remains cautious. It therefore expects its Engineered Conveyor Solutions arm to report significantly weaker results in the US than previously expected for the rest of the financial year.
----------
P2P Global Investments PLC will start trading on the London Stock Exchange's main market after its initial public offering, while Clipper Logistics PLC has priced its IPO at 100 pence a share, meaning it will raise about GBP100 million. P2P closed its placing and intermediaries offer on Wednesday, ahead of its admission. It had offered 20 million shares at 1,000 pence a share, meaning it will have an initial market capitalisation of GBP200 million. The company will invest in online and peer-to-peer lending, a small, but fast-growing part of the global financial system. Retail logistics company Clipper, meanwhile, said it will place 49.9 million shares in its IPO, with conditional dealings also starting. It will have 100 million shares in issue in total.
----------
GlaxoSmithKline PLC has invited private equity firms to bid for some of its older drugs in the latest step by Chief Executive Andrew Witty to reshape the UK’s biggest drugmaker, the Financial Times reports, citing people familiar with the situation. Private equity companies including Advent International, Blackstone and KKR are among those to have been alerted to the opportunity, The FT quoted the people as saying.
----------
Unite Group PLC said it has agreed to acquire and redevelop a 0.77 acre site from Portsmouth City Council, which subject to planning permission will be turned into a 830 bed student halls of residence. The financial terms of the deal have not been disclosed. Student accommodation provider Unite said the site which is located in Portsmouth's city centre should be completed in time for the 2016/17 academic year if planning permission is granted.
----------
MARKETS
----------
UK stocks trade mixed, with the FTSE 100 struggling to add to its recent strong gains, as it is weighed down by some of its mining constituents.
----------
FTSE 100: down 0.1% at 6864.41
FTSE 250: up 0.4% at 16011.62
AIM ALL-SHARE: down 0.1% at 810.56
----------
The pound has hit a two-day high against the dollar as a consumer sentiment index indicates that Britons have become more optimistic over nation's recovery.
----------
GBP-USD: up at USD1.6735
EUR-USD: up at USD1.3613

GOLD: down at USD1254.79 per ounce
OIL (Brent): down at USD109.84 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
An index measuring consumer sentiment in the UK came in with a score of 0 in May, polling company GfK said. That beat forecasts for a score of -2 and was up from -3 in April. The May reading represents a nine-year high score for the index. All the five sub-indicators, used to calculate the total index, witnessed growth in May.
----------
Germany's retail sales fell unexpectedly in April after rising for three consecutive months, official figures revealed. Retail sales turnover declined by a real 0.9% from March, when it was up 0.1%, Destatis reported. Sales were expected to rise by 0.2%. Meanwhile, on a yearly basis, retail sales grew 3.4%, reversing the 1.1% drop in March. The rate also exceeded 1.5% rise expected by economists.
----------
Italy's harmonized consumer price inflation slowed unexpectedly in May, preliminary estimate from the statistical office Istat showed. The harmonized index of consumer prices rose 0.4% year-on-year in May, slightly slower than the 0.5% increase posted in April. The rate was expected to remain at 0.5%. Similarly, consumer price inflation eased marginally to 0.5% from 0.6% a month ago. Prices were forecast to rise by 0.6%.
----------
Industrial output in Japan dipped 2.5% on month in April, the Ministry of Economy, Trade and Industry said. That missed forecasts for a decline of 2.0% following the 0.7% increase in March. On a yearly basis, industrial production added 4.1% - also missing expectations for 4.5% and down from 7.4% in the previous month.
----------
Nationwide core inflation in Japan was up 3.2% on year in April, the Ministry of Internal Affairs and Communications said. That topped forecasts for 3.1% and was up sharply from 1.3% in March. Overall nationwide CPI climbed 3.4% - in line with expectations and up from 1.6% in the previous month. Meanwhile, the same government ministry said average of household spending in Japan was down 4.6% on year in April, standing at 302,141. That missed forecasts for a decline of 3.4% following the 7.2% jump in March. It also said the unemployment rate in Japan was a seasonally adjusted 3.6% in April, unchanged from the previous month and in line with expectations.
----------
Four civilian observers from the Organization for Security and Co-operation in Europe held captive by pro-Russian militiamen in eastern Ukraine have been freed, separatist leader Alexei Chmilenko told Interfax. However, there was no official confirmation from the OSCE. Chmilenko, a leader of the self-proclaimed Luhansk People's Republic, said the incident was a warning to outsiders that they should not enter the area without prior notification, the Interfax news agency reported.
The Thai military junta is to send representatives to social media companies to ask them for access to chatrooms and groups that are deemed harmful to national security, reports said Friday.
----------
Facebook, Twitter, Google and popular instant messaging application Line are companies which the junta plans to talk to, a representative from Thailand's Ministry of Information and Communication Technology told Matichon Newspaper. The military government is asking for cooperation from the companies in taking down posts that are "sensitive" in the current political situation as well as group chats which might contain information deemed vital in protecting the nation.
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.


More News
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.